{"id":"AGY-FED-HEALTH-OTHER-018","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","eco":"","issuer":"William T. McDermott, Assistant Administrator, Diversion Control Division, DEA","authority":"21 U.S.C. 822(e); 21 C.F.R. 1301.12; 21 C.F.R. 1307.03","instrument":"DEA-DC-028 (DEA084), letter permitting DEA-registered hospitals and clinics to handle controlled substances at satellite locations under the existing registration during the COVID-19 emergency","title":"Hospital/Clinic Registration Exception (final)","dateIssued":"2020-04-10","effective":"2020-04-10 (digitally signed Apr. 11, 2020)","end":"For the duration of the public health emergency","startDate":"2020-04-10","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"addressees":["DEA-registered hospitals and clinics","manufacturers","distributors"],"clause":"the Drug Enforcement Administration (DEA) has learned that some DEA-registered hospital/clinics need to utilize additional satellite hospital/clinic locations to accommodate the large influx of patients presenting for treatment.... To facilitate appropriate patient care and assist the nation in responding effectively to these unprecedented scenarios that have arisen during the COVID-19 pandemic, DEA is issuing this letter to provide DEA-registered hospital/clinics with the flexibility to utilize alternate satellite hospital/clinic locations under their current registration.","enforcement":"Registration requirements under 21 U.S.C. 822(e) and 842","functions":["IP inpatient units and surge capacity","SC supply chain","ED emergency department"],"notes":"Predicate for field hospitals, convention-center surge sites and hotel step-down units.","sourceUrl":"https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-028)(DEA084)_Hospital_Clinic_Registration_Exception_(final).pdf","snapshot":"https://web.archive.org/web/20200419025705/https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-028)(DEA084)_Hospital_Clinic_Registration_Exception_(final).pdf","fileExists":true,"fileBytes":220797,"grade":"primary","character":"","description":"","collection":"AGY-FED-HEALTH-OTHER","url":"/library/AGY-FED-HEALTH-OTHER-018","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-018","citation":"William T. McDermott, Assistant Administrator, Diversion Control Division, DEA, DEA-DC-028 (DEA084), letter permitting DEA-registered hospitals and clinics to handle controlled substances at satellite locations under the existing registration during the COVID-19 emergency (Apr. 10, 2020) (Ex. AGY-FED-HEALTH-OTHER-018)","stateName":"","related":["AGY-FED-HEALTH-OTHER-017","AGY-FED-HEALTH-OTHER-019"]}